ClinicalTrials.gg
CompletedNCT07945301Updated Nov 18, 2026

Comparison of Hyaluronic Acid Versus EDTA as Adjunctive Therapy to Tunnel Technique for Gingival Recession.

An interventional study of Hyaluronic Acid (0.2%) and EDTA 24% in GINGIVAL RECESSION, sponsored by Al-Azhar University. Completed at 1 site in Egypt. Open to participants aged 25 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Al-Azhar University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Sep 2025, registered Nov 2026).
Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
25 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 53 studies in Gingival Recession with a site in Egypt — 14 open to participants now, 17 under way, 1 of them phase 3. Gingival Recession · Egypt.

Enrollment
9th of 50
30 · median 24
Started
2025
with 6 others
No phase
45 of 53
13 open now
Registered
53rd of 53
by date
Lead sponsor
2 of 53
Al-Azhar University

Among the 53 studies in Gingival Recession with a site in Egypt, this one is the 9th largest by enrollment of the 50 interventional ones that give a count, is one of 7 that started in 2025, is one of 45 with no phase, and was the 53rd registered.

Gingival Recession

430 studies on the registry are indexed under Gingival Recession; 106 are open to participants now.

Browse Gingival Recession studies →

Open to participants now

14 of the 53 studies in Gingival Recession with a site in Egypt are open now. Recruiting first, the newest first:

9 more — sign in →

All 14 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 63 Gingival Recession studies recruiting now, 30 (48%) set no upper age limit and 30 (48%) stop at 75 or younger; 1 takes children under 18; 36 take healthy volunteers.

This study: 25 Years to 40 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 53 studies in Gingival Recession with a site in Egypt, or all of them as a file.
02

Study summary

The objective of this study was to compare the clinical effects of hyaluronic acid (HA) and ethylenediaminetetraacetic acid (EDTA) as adjuncts to the tunnel surgical technique in the management of Miller Class I (RT1) gingival recession defects in the esthetic zone among systemically healthy patients.

A total of 30 systemically healthy patients presenting with RT1 gingival recession defects were randomly allocated into three groups, with 10 patients in each group. All patients underwent surgical treatment using the tunnel technique. In the first group, 0.2% hyaluronic acid gel (Gengigel®) was applied to the exposed root surface and within the prepared tunnel. In the second group, the exposed root surface was conditioned with 24% EDTA for 2 minutes, followed by saline irrigation. The third group received the tunnel technique alone and served as the control group.

Clinical outcomes were evaluated at baseline, 3 months, and 6 months postoperatively. The assessed clinical parameters included recession depth (RD), clinical attachment level (CAL), keratinized tissue width (KTW), probing depth (PD), plaque index (PI), and gingival index (GI), to evaluate changes in periodontal clinical conditions following treatment.

03

Conditions studied

  • GINGIVAL RECESSION

Browse trials for

04

Who can participate

Ages eligible
25 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 1- Presence of multiple gingival recession (at least two sites) defects on the labial/buccal surfaces of the teeth either in maxilla or mandible diagnosed as type1 gingival recession (RT1).

    2- Radiographic evidence of sufficient interdental bone (the distance between the crestal bone and cementoenamel junction (CEJ) as ≤2 mm).

    3- Presence of width of keratinized gingiva (WKG) apical to recession ≥3 mm. 4- Male or female aged from 25 - 40 years old

Exclusion criteria

Exclusion Criteria:

- 1- Smoking patient 2- Pregnancy breastfeeding patients. 3- Patients with systemic conditions which could affect the outcome of periodontal surgery.

4- Previous periodontal therapy in last 6 month

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Tunnel technique with Hyaluronic Acid

    Biological: Hyaluronic Acid (0.2%)

  • Experimental
    Tunnel technique with EDETA

    Biological: EDTA 24%

  • Active comparator
    tunnel technique alone ( control group)

    Procedure: tunnel technique

Interventions

  • BiologicalHyaluronic AcidStudies of Hyaluronic AcidHyaluronic Acid pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Application of Hyaluronic Acid gel as an adjunct to the tunnel technique.

  • BiologicalEDTA 24%

    Application of EDTA as an adjunct to the tunnel technique

  • Proceduretunnel technique

    Surgical correction of gingival recession using the tunnel technique alone without any adjunct materials.

06

What researchers measure

Primary outcomes

  1. Percentage of root coverage assessed using a periodontal probe

    Root coverage will be assessed clinically using (unc15) periodontal probe at baseline and at 3 and 6 months post-treatment. The percentage of root coverage will be calculated by measuring the reduction in gingival recession depth and comparing it with the baseline measurement. The results will be recorded and compared across the follow-up periods to evaluate the effectiveness of the treatment.

    Time frame: 3 month and 6 months from base line

Secondary outcomes

  1. Recession depth

    Recession depth will be measured in millimeters using a UNC-15 periodontal probe as the distance from the cemento-enamel junction (CEJ) to the gingival margin. Measurements will be recorded at baseline and at 3 and 6 months post-treatment to evaluate changes in gingival recession depth over time

    Time frame: 3 month and 6 months from base line

  2. Keratinized Gingiva

    Keratinized gingiva width will be measured in millimeters using a UNC-15 periodontal probe as the distance from the gingival margin to the mucogingival junction. Measurements will be recorded at baseline and at 3 and 6 months post-treatment to evaluate changes in keratinized gingiva width.

    Time frame: 3 month and 6 months from base line

  3. Probing depth

    Time frame: 3 month and 6 months from base line

  4. Plaque Index

    Time frame: 3 month and 6 months from base line

  5. Gingival Index

    Time frame: 3 month and 6 months from base line

  6. clinical attachment

    Time frame: 3 month and 6 months from base line

07

Study locations

1 site
  • Faculty of Dentistry, Cairo University
    Cairo, Cairo Governorate, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2025 to primary completion in Jan 2026, 3 months.

Of 236 non-industry interventional studies with no phase under Gingival Recession, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's 3 months is below that.

Counting every sponsor, half of 238 studies reached it within 19 months; a quarter within 11 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 18, 2026
StartActual
Sep 25, 2025
Primary completionActual
Jan 20, 2026
CompletionActual
May 25, 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07945301
Responsible party
Muna Fuad Rashed Abdo (MASTER DEGREE CANDIDANTE, Al-Azhar University) — Principal investigator
First posted
Nov 18, 2026
Start date
Sep 25, 2025
Primary completion
Jan 20, 2026
Completion
May 25, 2026
Last update
Nov 18, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Hyaluronic Acid

Start the discussion